DRONEDARONE

DRONEDARONE was reported 10242 times

DRONEDARONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SUBCHONDRAL INSUFFICIENCY FRACTURE 11 0.2683
1 ELECTROCARDIOGRAM R ON T PHENOMENON 5 0.1000
2 DEVICE PACING ISSUE 4 0.0471
3 DEPOSIT EYE 7 0.0261
4 ENTEROBACTER PNEUMONIA 4 0.0256
5 XANTHOPSIA 8 0.0217
6 CATHETER SITE HAEMATOMA 6 0.0203
7 HAEMORRHAGIC ANAEMIA 81 0.0184
8 HAEMORRHAGIC ARTERIOVENOUS MALFORMATION 16 0.0171
9 GASTROENTERITIS CLOSTRIDIAL 6 0.0171
10 CANDIDA PNEUMONIA 5 0.0155
11 CARDIAC ABLATION 27 0.0151
12 ATRIAL FIBRILLATION 1428 0.0146
13 SINOATRIAL BLOCK 8 0.0134
14 ATRIAL FLUTTER 106 0.0133
15 ANTICOAGULATION DRUG LEVEL INCREASED 4 0.0125
16 CARDIOVERSION 16 0.0114
17 PERICARDIAL HAEMORRHAGE 20 0.0091
18 TORSADE DE POINTES 67 0.0085
19 SINUS ARREST 13 0.0083
20 BRAIN NATRIURETIC PEPTIDE INCREASED 25 0.0081
21 DIVERTICULUM INTESTINAL HAEMORRHAGIC 18 0.0080
22 LOWER GASTROINTESTINAL HAEMORRHAGE 59 0.0080
23 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 4 0.0080
24 BLOOD LOSS ANAEMIA 18 0.0079
25 CHOLANGITIS SCLEROSING 16 0.0078
26 ACUTE LEFT VENTRICULAR FAILURE 5 0.0074
27 RENAL HAEMORRHAGE 15 0.0074
28 CHOLESTATIC LIVER INJURY 16 0.0072
29 VENTRICULAR TACHYCARDIA 118 0.0071
30 SUPRAVENTRICULAR EXTRASYSTOLES 24 0.0071
31 INTERNATIONAL NORMALISED RATIO INCREASED 192 0.0067
32 PULMONARY TOXICITY 44 0.0062
33 VENTRICULAR FIBRILLATION 69 0.0062
34 BASAL GANGLIA HAEMORRHAGE 5 0.0061
35 NEUROENDOCRINE CARCINOMA OF THE SKIN 6 0.0061
36 GLOMERULAR FILTRATION RATE DECREASED 75 0.0061
37 BRADYARRHYTHMIA 10 0.0061
38 DILATATION ATRIAL 7 0.0060
39 INFLAMMATORY PAIN 4 0.0059
40 EXTRASYSTOLES 41 0.0059
41 NODAL ARRHYTHMIA 5 0.0058
42 CREATININE RENAL CLEARANCE DECREASED 23 0.0057
43 ALVEOLITIS 8 0.0057
44 INTRA-ABDOMINAL HAEMATOMA 7 0.0056
45 NEUROMYOPATHY 6 0.0056
46 TEMPORAL ARTERITIS 5 0.0054
47 ORTHOPNOEA 17 0.0053
48 CARDIOACTIVE DRUG LEVEL INCREASED 7 0.0053
49 ATRIOVENTRICULAR BLOCK SECOND DEGREE 16 0.0053
50 TACHYARRHYTHMIA 13 0.0052
51 GASTROINTESTINAL HAEMORRHAGE 421 0.0050
52 MUCOSAL DISORDER 5 0.0050
53 CARDIOVASCULAR INSUFFICIENCY 8 0.0049
54 UPPER GASTROINTESTINAL HAEMORRHAGE 82 0.0049
55 COAGULOPATHY 81 0.0049
56 ATRIOVENTRICULAR BLOCK FIRST DEGREE 21 0.0048
57 BLOOD CREATININE INCREASED 311 0.0048
58 HEART VALVE REPLACEMENT 7 0.0047
59 LEFT ATRIAL DILATATION 6 0.0047
60 INTERNATIONAL NORMALISED RATIO DECREASED 19 0.0047
61 AXONAL NEUROPATHY 4 0.0046
62 HEPATOCELLULAR INJURY 65 0.0046
63 VERTIGO POSITIONAL 8 0.0046
64 CARDIAC TAMPONADE 21 0.0044
65 ATRIAL TACHYCARDIA 9 0.0043
66 HEART RATE DECREASED 150 0.0043
67 VENTRICULAR EXTRASYSTOLES 44 0.0042
68 HEPATIC CONGESTION 4 0.0042
69 HEPATITIS TOXIC 11 0.0042
70 BLOOD URINE 4 0.0041
71 SUDDEN CARDIAC DEATH 14 0.0041
72 BLOOD IRON ABNORMAL 4 0.0041
73 CARDIAC FIBRILLATION 6 0.0041
74 GASTRITIS HAEMORRHAGIC 6 0.0040
75 MIXED LIVER INJURY 12 0.0040
76 SMALL INTESTINAL HAEMORRHAGE 8 0.0040
77 SINUS ARRHYTHMIA 5 0.0038
78 HYPERTHYROIDISM 55 0.0038
79 HAEMOTHORAX 11 0.0038
80 EXTRADURAL HAEMATOMA 5 0.0038
81 AMAUROSIS FUGAX 4 0.0037
82 HEART RATE IRREGULAR 82 0.0036
83 CYTOLYTIC HEPATITIS 12 0.0036
84 ARRHYTHMIA 171 0.0036
85 HEPATORENAL SYNDROME 6 0.0036
86 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 18 0.0036
87 CEREBELLAR HAEMORRHAGE 5 0.0035
88 INTERNATIONAL NORMALISED RATIO ABNORMAL 12 0.0035
89 POST HERPETIC NEURALGIA 5 0.0035
90 SINUS BRADYCARDIA 33 0.0034
91 SUBDURAL HAEMORRHAGE 9 0.0033
92 HAEMORRHOIDAL HAEMORRHAGE 16 0.0033
93 PULMONARY FIBROSIS 62 0.0032
94 INTRAVENTRICULAR HAEMORRHAGE 8 0.0032
95 CARDIAC PACEMAKER INSERTION 19 0.0032
96 HEPATIC NECROSIS 12 0.0032
97 BLOOD BICARBONATE DECREASED 6 0.0032
98 NOCTURNAL DYSPNOEA 4 0.0031
99 LARGE INTESTINAL HAEMORRHAGE 7 0.0031
100 RENAL FAILURE ACUTE 131 0.0031
101 ABDOMINAL WALL HAEMATOMA 6 0.0031
102 HEART RATE ABNORMAL 17 0.0030
103 ORGANISING PNEUMONIA 15 0.0030
104 QUADRIPARESIS 5 0.0030
105 BRADYCARDIA 159 0.0030
106 NORMOCHROMIC NORMOCYTIC ANAEMIA 9 0.0030
107 BILIRUBIN CONJUGATED INCREASED 7 0.0030
108 WOUND HAEMORRHAGE 11 0.0030
109 DRUG INTERACTION 471 0.0030
110 INTRA-ABDOMINAL HAEMORRHAGE 7 0.0029
111 ISCHAEMIC HEPATITIS 4 0.0029
112 INTERNATIONAL NORMALISED RATIO FLUCTUATION 6 0.0029
113 BLOOD CREATININE ABNORMAL 10 0.0029
114 ACUTE PULMONARY OEDEMA 16 0.0028
115 URINARY BLADDER HAEMORRHAGE 6 0.0028
116 ATRIOVENTRICULAR BLOCK 22 0.0028
117 OPTIC NEUROPATHY 6 0.0028
118 BUNDLE BRANCH BLOCK LEFT 12 0.0028
119 MITRAL VALVE DISEASE 5 0.0028
120 DIVERTICULUM 20 0.0028
121 HYPERPARATHYROIDISM SECONDARY 7 0.0028
122 CARDIAC FAILURE 223 0.0028
123 GAMMA-GLUTAMYLTRANSFERASE INCREASED 61 0.0027
124 PULMONARY SEPSIS 4 0.0027
125 HAEMORRHAGE URINARY TRACT 7 0.0027
126 NODAL RHYTHM 4 0.0027
127 ATRIOVENTRICULAR BLOCK COMPLETE 18 0.0027
128 CARDIAC FAILURE CONGESTIVE 213 0.0026
129 RECTAL HAEMORRHAGE 113 0.0026
130 CARDIAC FLUTTER 17 0.0026
131 HAEMATURIA 90 0.0026
132 READING DISORDER 6 0.0026
133 INTERNAL HAEMORRHAGE 30 0.0026
134 CONTRAINDICATION TO MEDICAL TREATMENT 4 0.0026
135 CONJUNCTIVAL HAEMORRHAGE 10 0.0026
136 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
137 SYNOVIAL CYST 12 0.0026
138 DIASTOLIC DYSFUNCTION 8 0.0026
139 EJECTION FRACTION DECREASED 40 0.0026
140 PULMONARY FUNCTION TEST ABNORMAL 4 0.0026
141 LIVER FUNCTION TEST ABNORMAL 74 0.0025
142 GASTRIC ULCER HAEMORRHAGE 14 0.0025
143 PROTHROMBIN TIME PROLONGED 15 0.0025
144 ELECTROCARDIOGRAM QT PROLONGED 90 0.0025
145 PULSE ABNORMAL 6 0.0025
146 GINGIVAL BLEEDING 34 0.0025
147 CARDIAC DISCOMFORT 5 0.0025
148 HEPATITIS ACUTE 16 0.0025
149 HEART VALVE INCOMPETENCE 7 0.0024
150 ATRIAL THROMBOSIS 5 0.0024
151 DYSPNOEA AT REST 7 0.0024
152 BLOOD UREA INCREASED 40 0.0024
153 CONTRAINDICATED PRODUCT PRESCRIBED 4 0.0024
154 SUBDURAL HAEMATOMA 34 0.0024
155 BLOOD AMYLASE INCREASED 4 0.0023
156 SHOCK HAEMORRHAGIC 19 0.0023
157 HAEMORRHAGIC STROKE 18 0.0023
158 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 6 0.0023
159 INTRACARDIAC THROMBUS 7 0.0023
160 AZOTAEMIA 9 0.0023
161 BLOOD POTASSIUM ABNORMAL 6 0.0022
162 TRANSAMINASES INCREASED 49 0.0022
163 BLOOD THYROID STIMULATING HORMONE DECREASED 10 0.0022
164 VENTRICULAR ARRHYTHMIA 8 0.0022
165 PNEUMONIA KLEBSIELLA 4 0.0022
166 THYROID FUNCTION TEST ABNORMAL 9 0.0022
167 HAEMANGIOMA 5 0.0022
168 NEPHROGENIC ANAEMIA 10 0.0022
169 GASTRITIS EROSIVE 10 0.0021
170 HAEMORRHAGE INTRACRANIAL 32 0.0021
171 MENISCUS INJURY 13 0.0021
172 EYE HAEMORRHAGE 28 0.0021
173 LONG QT SYNDROME 5 0.0021
174 ECCHYMOSIS 14 0.0020
175 LUNG INFILTRATION 18 0.0020
176 RETROPERITONEAL HAEMORRHAGE 5 0.0020
177 JAUNDICE 54 0.0020
178 MELAENA 44 0.0020
179 ORGAN FAILURE 8 0.0020
180 HAEMORRHAGE SUBCUTANEOUS 7 0.0020
181 BLOOD THYROID STIMULATING HORMONE INCREASED 18 0.0020
182 RENAL FAILURE CHRONIC 15 0.0019
183 INCREASED UPPER AIRWAY SECRETION 10 0.0019
184 PHOTOSENSITIVITY REACTION 32 0.0019
185 BLOOD ALKALINE PHOSPHATASE INCREASED 48 0.0019
186 POSTMENOPAUSAL HAEMORRHAGE 5 0.0019
187 ALANINE AMINOTRANSFERASE INCREASED 117 0.0019
188 BLOOD URINE PRESENT 36 0.0019
189 SUDDEN DEATH 20 0.0019
190 MEDICATION RESIDUE PRESENT 9 0.0019
191 ASPARTATE AMINOTRANSFERASE INCREASED 100 0.0019
192 IRON DEFICIENCY ANAEMIA 17 0.0018
193 REACTION TO DRUG EXCIPIENTS 4 0.0018
194 PALPITATIONS 214 0.0018
195 HEPATIC FAILURE 55 0.0018
196 BLOOD BILIRUBIN INCREASED 49 0.0018
197 BLOOD CREATINE INCREASED 8 0.0018
198 HEART RATE INCREASED 179 0.0018
199 OEDEMA PERIPHERAL 220 0.0018
200 FAECES PALE 4 0.0018
201 HAEMATOMA 46 0.0018
202 OLIGURIA 11 0.0018
203 PAPILLOEDEMA 8 0.0018
204 CARDIAC VALVE DISEASE 10 0.0017
205 LEFT VENTRICULAR FAILURE 6 0.0017
206 DYSPNOEA EXERTIONAL 65 0.0017
207 EMBOLIC STROKE 6 0.0017
208 HAEMORRHAGIC DIATHESIS 6 0.0017
209 URINE ANALYSIS ABNORMAL 5 0.0017
210 HYPERVOLAEMIA 8 0.0016
211 ABDOMINAL TENDERNESS 8 0.0016
212 ACUTE HEPATIC FAILURE 22 0.0016
213 LACERATION 15 0.0016
214 PULMONARY CONGESTION 21 0.0016
215 EPISTAXIS 119 0.0016
216 AUTOIMMUNE THYROIDITIS 6 0.0016
217 PRODUCT CONTAMINATION PHYSICAL 4 0.0016
218 BLADDER PAIN 5 0.0016
219 SUBARACHNOID HAEMORRHAGE 16 0.0016
220 INCREASED BRONCHIAL SECRETION 4 0.0016
221 MYOSITIS 14 0.0016
222 PERICARDIAL EFFUSION 36 0.0016
223 COMPARTMENT SYNDROME 4 0.0015
224 CORONARY ARTERY OCCLUSION 21 0.0015
225 ELECTROCARDIOGRAM ABNORMAL 12 0.0015
226 BUNDLE BRANCH BLOCK RIGHT 7 0.0015
227 DYSPNOEA 850 0.0015
228 HEPATIC ENCEPHALOPATHY 14 0.0015
229 MUSCLE HAEMORRHAGE 6 0.0015
230 POTENTIATING DRUG INTERACTION 5 0.0015
231 INTERSTITIAL LUNG DISEASE 72 0.0015
232 BLOOD POTASSIUM INCREASED 24 0.0015
233 GASTRIC HAEMORRHAGE 17 0.0015
234 RENAL FAILURE 193 0.0015
235 INTESTINAL ISCHAEMIA 8 0.0015
236 EOSINOPHILIC OESOPHAGITIS 4 0.0014
237 MICTURITION DISORDER 5 0.0014
238 CHROMATURIA 32 0.0014
239 CARDIAC FAILURE CHRONIC 6 0.0014
240 OEDEMA 76 0.0014
241 PRODUCT USE COMPLAINT 22 0.0014
242 CARDIAC OPERATION 12 0.0014
243 CARDIOGENIC SHOCK 20 0.0014
244 HEPATIC ENZYME INCREASED 95 0.0014
245 PULMONARY HYPERTENSION 29 0.0014
246 EMPHYSEMA 14 0.0014
247 TRICUSPID VALVE INCOMPETENCE 11 0.0014
248 PULMONARY OEDEMA 62 0.0014
249 RALES 8 0.0014
250 POST PROCEDURAL HAEMORRHAGE 16 0.0014
251 URINE OUTPUT DECREASED 12 0.0014
252 PULMONARY FUNCTION TEST DECREASED 6 0.0014
253 LUMBAR SPINAL STENOSIS 4 0.0014
254 HEPATITIS 35 0.0014
255 MOUTH HAEMORRHAGE 10 0.0014
256 HAEMOPTYSIS 38 0.0014
257 SUPRAVENTRICULAR TACHYCARDIA 13 0.0014
258 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12 0.0014
259 CHOLESTASIS 26 0.0014
260 PETECHIAE 14 0.0013
261 CEREBRAL HAEMORRHAGE 48 0.0013
262 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
263 COLITIS ISCHAEMIC 9 0.0013
264 MULTI-ORGAN FAILURE 23 0.0013
265 ANORECTAL DISCOMFORT 7 0.0013
266 PLEURAL EFFUSION 80 0.0013
267 FLUID OVERLOAD 19 0.0013
268 LIPASE INCREASED 10 0.0013
269 TRANSIENT ISCHAEMIC ATTACK 44 0.0013
270 OESOPHAGEAL ULCER 5 0.0013
271 FAECES DISCOLOURED 28 0.0013
272 HYPERKALAEMIA 45 0.0013
273 HAEMORRHAGE 134 0.0013
274 BLOOD PRESSURE DECREASED 85 0.0013
275 MYOPATHY 11 0.0013
276 OESOPHAGEAL PAIN 5 0.0013
277 IDIOPATHIC PULMONARY FIBROSIS 5 0.0013
278 STREPTOCOCCAL INFECTION 7 0.0013
279 FOREIGN BODY 5 0.0012
280 FLUID RETENTION 63 0.0012
281 HIATUS HERNIA 16 0.0012
282 PRESYNCOPE 30 0.0012
283 CONTUSION 117 0.0012
284 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 4 0.0012
285 VEIN DISORDER 6 0.0012
286 PROSTATE CANCER METASTATIC 4 0.0012
287 INCREASED TENDENCY TO BRUISE 11 0.0012
288 SINUS HEADACHE 7 0.0012
289 AMMONIA INCREASED 6 0.0012
290 HEPATIC PAIN 5 0.0012
291 POLYNEUROPATHY 14 0.0012
292 VARICOSE VEIN 6 0.0012
293 HAEMATOCRIT DECREASED 23 0.0012
294 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
295 SKIN SWELLING 10 0.0012
296 ANGINA PECTORIS 33 0.0012
297 ACUTE RESPIRATORY FAILURE 22 0.0011
298 TONGUE DISCOLOURATION 5 0.0011
299 GROIN PAIN 10 0.0011
300 JAUNDICE CHOLESTATIC 4 0.0011
301 FOOD POISONING 6 0.0011
302 COMPRESSION FRACTURE 6 0.0011
303 GOUT 20 0.0011
304 VISUAL FIELD DEFECT 8 0.0011
305 SYNCOPE 110 0.0011
306 MACULAR DEGENERATION 13 0.0011
307 RENAL FUNCTION TEST ABNORMAL 5 0.0011
308 PERFORMANCE STATUS DECREASED 5 0.0011
309 RASH PRURITIC 58 0.0011
310 TACHYCARDIA 95 0.0011
311 CARDIAC ARREST 88 0.0011
312 CARDIAC DISORDER 99 0.0011
313 UNDERDOSE 77 0.0011
314 CARDIAC FAILURE ACUTE 7 0.0010
315 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
316 HYPOVOLAEMIC SHOCK 5 0.0010
317 SCRATCH 11 0.0010
318 EXERCISE TOLERANCE DECREASED 6 0.0010
319 ULCER HAEMORRHAGE 7 0.0010
320 RASH VESICULAR 5 0.0010
321 ANAEMIA 197 0.0010
322 DIZZINESS POSTURAL 10 0.0010
323 CHEST DISCOMFORT 105 0.0010
324 EPIGASTRIC DISCOMFORT 4 0.0010
325 ASTHENIA 385 0.0010
326 RENAL IMPAIRMENT 86 0.0010
327 ONYCHOCLASIS 7 0.0010
328 RESPIRATION ABNORMAL 7 0.0010
329 ISCHAEMIC STROKE 18 0.0010
330 SLEEP APNOEA SYNDROME 19 0.0010
331 HYPOXIA 35 0.0010
332 BLINDNESS UNILATERAL 14 0.0010
333 HAND FRACTURE 7 0.0010
334 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 5 0.0010
335 MITRAL VALVE INCOMPETENCE 11 0.0010
336 AGEUSIA 24 0.0010
337 HYPONATRAEMIA 54 0.0010
338 GASTRITIS 25 0.0009
339 BLOOD LACTIC ACID INCREASED 5 0.0009
340 PHOTOPSIA 6 0.0009
341 HYPOTENSION 190 0.0009
342 SUNBURN 7 0.0009
343 LUNG DISORDER 46 0.0009
344 FEELING COLD 26 0.0009
345 HYPOMAGNESAEMIA 13 0.0009
346 PRODUCT SIZE ISSUE 5 0.0009
347 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 48 0.0009
348 JAW DISORDER 5 0.0009
349 DIZZINESS 454 0.0009
350 WALKING AID USER 6 0.0009
351 CHOKING SENSATION 5 0.0009
352 DYSPHAGIA 86 0.0009
353 HYPOACUSIS 39 0.0009
354 RESPIRATORY DISORDER 27 0.0009
355 PULMONARY HAEMORRHAGE 7 0.0009
356 DYSPEPSIA 88 0.0009
357 HYPERCALCAEMIA 11 0.0009
358 GENERALISED OEDEMA 11 0.0009
359 PRODUCT LABEL ISSUE 6 0.0009
360 CIRCULATORY COLLAPSE 15 0.0009
361 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
362 WHEEZING 52 0.0009
363 BLOOD PRESSURE FLUCTUATION 21 0.0009
364 WEIGHT INCREASED 195 0.0009
365 HAEMATOCHEZIA 48 0.0009
366 MUSCLE DISORDER 7 0.0009
367 HYPERTRANSAMINASAEMIA 6 0.0009
368 LOCAL SWELLING 15 0.0009
369 ABDOMINAL DISCOMFORT 144 0.0009
370 DIARRHOEA HAEMORRHAGIC 8 0.0009
371 FLANK PAIN 8 0.0009
372 HEPATOTOXICITY 19 0.0009
373 DUODENAL ULCER 6 0.0008
374 RASH GENERALISED 22 0.0008
375 RENAL PAIN 9 0.0008
376 THYROID DISORDER 13 0.0008
377 PULSE ABSENT 4 0.0008
378 DECREASED ACTIVITY 9 0.0008
379 HEARING IMPAIRED 5 0.0008
380 PLATELET COUNT ABNORMAL 5 0.0008
381 NOCTURIA 10 0.0008
382 END STAGE RENAL DISEASE 15 0.0008
383 TENSION 5 0.0008
384 INCORRECT DOSAGE ADMINISTERED 4 0.0008
385 PRODUCTIVE COUGH 39 0.0008
386 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
387 SENSORY DISTURBANCE 13 0.0008
388 MUSCLE STRAIN 7 0.0008
389 HAEMOGLOBIN DECREASED 83 0.0008
390 CHOLANGITIS 5 0.0008
391 FATIGUE 627 0.0008
392 ORTHOSTATIC HYPOTENSION 14 0.0008
393 NERVOUSNESS 42 0.0008
394 GASTROINTESTINAL DISORDER 72 0.0008
395 HEPATIC ENZYME ABNORMAL 4 0.0008
396 BLOOD CREATINE PHOSPHOKINASE INCREASED 23 0.0008
397 PHOTOPHOBIA 15 0.0008
398 DRUG-INDUCED LIVER INJURY 25 0.0008
399 ERYSIPELAS 4 0.0008
400 BLOOD COUNT ABNORMAL 12 0.0008
401 KLEBSIELLA INFECTION 4 0.0008
402 DRUG TOLERANCE 4 0.0008
403 POOR QUALITY SLEEP 17 0.0008
404 SCAB 9 0.0008
405 AORTIC ANEURYSM 6 0.0008
406 TROPONIN INCREASED 6 0.0008
407 BOWEL MOVEMENT IRREGULARITY 6 0.0008
408 LETHARGY 45 0.0008
409 HAEMARTHROSIS 7 0.0008
410 PHARYNGEAL OEDEMA 12 0.0008
411 RIB FRACTURE 16 0.0008
412 ANKLE FRACTURE 12 0.0008
413 LIVER INJURY 19 0.0008
414 COUGH 217 0.0008
415 LUNG INFECTION 12 0.0008
416 HYPERBILIRUBINAEMIA 8 0.0008
417 CHEST PAIN 143 0.0008
418 TREMOR 128 0.0008
419 WRONG TECHNIQUE IN DRUG USAGE PROCESS 28 0.0008
420 HAEMORRHOIDS 15 0.0008
421 PRODUCT ODOUR ABNORMAL 8 0.0008
422 POLYP 5 0.0008
423 ARTERIAL OCCLUSIVE DISEASE 6 0.0008
424 PULMONARY ARTERIAL HYPERTENSION 11 0.0008
425 ACUTE KIDNEY INJURY 116 0.0008
426 DIVERTICULITIS 21 0.0008
427 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
428 DIARRHOEA 487 0.0008
429 JOINT SWELLING 91 0.0008
430 PERSONALITY CHANGE 7 0.0008
431 HEPATIC STEATOSIS 14 0.0008
432 SKIN DISORDER 25 0.0007
433 BODY HEIGHT DECREASED 8 0.0007
434 FULL BLOOD COUNT DECREASED 15 0.0007
435 SQUAMOUS CELL CARCINOMA 7 0.0007
436 BRONCHITIS 55 0.0007
437 BLOOD SODIUM DECREASED 14 0.0007
438 RESPIRATORY FAILURE 54 0.0007
439 HYPOKALAEMIA 34 0.0007
440 ACUTE RESPIRATORY DISTRESS SYNDROME 13 0.0007
441 PNEUMONITIS 20 0.0007
442 POLYURIA 6 0.0007
443 TENDON RUPTURE 9 0.0007
444 ABASIA 18 0.0007
445 GASTRIC DISORDER 25 0.0007
446 PERIPHERAL SWELLING 112 0.0007
447 CONTRAINDICATED PRODUCT ADMINISTERED 22 0.0007
448 DRUG LEVEL INCREASED 12 0.0007
449 ATELECTASIS 7 0.0007
450 LYMPHOEDEMA 5 0.0007
451 LARGE INTESTINE POLYP 5 0.0007
452 ORAL DISCOMFORT 10 0.0007
453 TOOTH DISORDER 16 0.0007
454 PANCREATITIS 38 0.0007
455 DEMENTIA 20 0.0007
456 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
457 MUSCULAR WEAKNESS 81 0.0007
458 VITREOUS FLOATERS 7 0.0007
459 MUSCULOSKELETAL CHEST PAIN 11 0.0007
460 GAIT DISTURBANCE 136 0.0007
461 EYE INFECTION 8 0.0007
462 COLECTOMY 4 0.0007
463 REBOUND EFFECT 8 0.0007
464 SEASONAL ALLERGY 10 0.0007
465 PERONEAL NERVE PALSY 4 0.0007
466 MICTURITION URGENCY 8 0.0007
467 BLOOD MAGNESIUM DECREASED 6 0.0007
468 NODULE 9 0.0007
469 ELECTROLYTE IMBALANCE 8 0.0007
470 RENAL DISORDER 32 0.0007
471 NAIL DISORDER 6 0.0007
472 ABDOMINAL DISTENSION 71 0.0007
473 HYPERCHLORHYDRIA 4 0.0007
474 ARTHROPOD BITE 5 0.0007
475 SKIN HAEMORRHAGE 10 0.0007
476 ERUCTATION 13 0.0007
477 ABDOMINAL PAIN UPPER 138 0.0007
478 FLATULENCE 38 0.0007
479 FEELING ABNORMAL 160 0.0007
480 HEPATITIS CHOLESTATIC 4 0.0007
481 HEAD INJURY 21 0.0007
482 ARTHRITIS 52 0.0007
483 INJECTION SITE VESICLES 4 0.0007
484 INGUINAL HERNIA 4 0.0007
485 HYPOTHYROIDISM 21 0.0007
486 PERIPHERAL COLDNESS 9 0.0007
487 ACIDOSIS 5 0.0007
488 OFF LABEL USE 571 0.0007
489 LIVER FUNCTION TEST INCREASED 14 0.0007
490 SWELLING 61 0.0007
491 SLEEP DISORDER 46 0.0007
492 DYSSTASIA 19 0.0007
493 MUSCULOSKELETAL PAIN 34 0.0006
494 MENTAL STATUS CHANGES 18 0.0006
495 WEIGHT DECREASED 180 0.0006
496 ACUTE MYOCARDIAL INFARCTION 19 0.0006
497 HYPOALBUMINAEMIA 5 0.0006
498 MIDDLE INSOMNIA 12 0.0006
499 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
500 GASTROINTESTINAL PAIN 7 0.0006
501 DIALYSIS 9 0.0006
502 BLOOD POTASSIUM DECREASED 19 0.0006
503 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
504 RESTLESSNESS 23 0.0006
505 OXYGEN SATURATION DECREASED 35 0.0006
506 PROCTALGIA 4 0.0006
507 HIP FRACTURE 20 0.0006
508 HAEMOGLOBIN ABNORMAL 4 0.0006
509 STENT PLACEMENT 5 0.0006
510 MYASTHENIA GRAVIS 5 0.0006
511 INCOHERENT 4 0.0006
512 PNEUMONIA 199 0.0006
513 RESPIRATORY TRACT INFECTION 16 0.0006
514 VISUAL IMPAIRMENT 76 0.0006
515 BRADYPHRENIA 4 0.0006
516 RENAL TUBULAR NECROSIS 6 0.0006
517 CARDIOMYOPATHY 9 0.0006
518 JOINT INJURY 13 0.0006
519 BLOOD PRESSURE INCREASED 93 0.0006
520 LEUKOCYTOSIS 11 0.0006
521 UPPER RESPIRATORY TRACT INFECTION 28 0.0006
522 NAUSEA 479 0.0006
523 PRURITUS GENERALISED 13 0.0006
524 VASCULITIS 7 0.0006
525 POLLAKIURIA 25 0.0006
526 CONDITION AGGRAVATED 182 0.0006
527 MALIGNANT MELANOMA 8 0.0006
528 CYSTITIS 19 0.0006
529 BLOOD GLUCOSE ABNORMAL 11 0.0006
530 HAEMODIALYSIS 5 0.0006
531 RED BLOOD CELL COUNT DECREASED 17 0.0006
532 DECREASED APPETITE 138 0.0006
533 EYELID PTOSIS 6 0.0006
534 DRY THROAT 6 0.0006
535 CHOLECYSTITIS 7 0.0006
536 ABNORMAL LOSS OF WEIGHT 4 0.0006
537 DRUG ADMINISTRATION ERROR 18 0.0006
538 LIVER DISORDER 26 0.0006
539 HEPATIC CIRRHOSIS 11 0.0006
540 VITAMIN D DECREASED 5 0.0006
541 EYE MOVEMENT DISORDER 4 0.0006
542 MYALGIA 99 0.0006
543 ANURIA 5 0.0006
544 ASCITES 17 0.0006
545 LOSS OF CONSCIOUSNESS 74 0.0006
546 VISION BLURRED 79 0.0006
547 AUTOIMMUNE HEPATITIS 4 0.0006
548 DEAFNESS 15 0.0006
549 WEIGHT FLUCTUATION 6 0.0006
550 WHITE BLOOD CELL COUNT INCREASED 22 0.0006
551 CEREBROVASCULAR ACCIDENT 97 0.0006
552 DYSURIA 21 0.0006
553 GENERAL PHYSICAL HEALTH DETERIORATION 66 0.0006
554 CARDIOMEGALY 7 0.0006
555 COLD SWEAT 10 0.0006
556 IMMUNOSUPPRESSION 5 0.0006
557 SKIN DISCOLOURATION 26 0.0006
558 PURPURA 5 0.0006
559 DYSPHONIA 33 0.0006
560 RESPIRATORY RATE INCREASED 5 0.0006
561 GASTROOESOPHAGEAL REFLUX DISEASE 45 0.0006
562 DYSARTHRIA 21 0.0006
563 URINARY TRACT INFECTION 95 0.0006
564 DERMATITIS ALLERGIC 7 0.0006
565 MUSCLE SPASMS 102 0.0006
566 CHRONIC KIDNEY DISEASE 42 0.0006
567 CLOSTRIDIUM DIFFICILE INFECTION 12 0.0005
568 RASH PUSTULAR 4 0.0005
569 TOOTH FRACTURE 6 0.0005
570 RASH ERYTHEMATOUS 26 0.0005
571 RESPIRATORY DISTRESS 15 0.0005
572 RASH MACULAR 19 0.0005
573 ABNORMAL DREAMS 15 0.0005
574 UROSEPSIS 5 0.0005
575 UNEVALUABLE EVENT 41 0.0005
576 CEREBRAL DISORDER 4 0.0005
577 FUNGAL INFECTION 18 0.0005
578 URINARY RETENTION 18 0.0005
579 CATARACT 32 0.0005
580 THINKING ABNORMAL 10 0.0005
581 BACTERIAL INFECTION 10 0.0005
582 HEMIPARESIS 9 0.0005
583 ARTERIOSCLEROSIS 5 0.0005
584 TOOTH INFECTION 7 0.0005
585 THERAPEUTIC RESPONSE DECREASED 32 0.0005
586 BURNING SENSATION 37 0.0005
587 RHINORRHOEA 34 0.0005
588 HAEMODYNAMIC INSTABILITY 4 0.0005
589 DEHYDRATION 70 0.0005
590 FEELING JITTERY 10 0.0005
591 DISCOMFORT 32 0.0005
592 ABDOMINAL PAIN 122 0.0005
593 HAIR TEXTURE ABNORMAL 7 0.0005
594 FALL 174 0.0005
595 KNEE ARTHROPLASTY 11 0.0005
596 EXTRA DOSE ADMINISTERED 21 0.0005
597 FREQUENT BOWEL MOVEMENTS 14 0.0005
598 LIMB DISCOMFORT 16 0.0005
599 IMPAIRED GASTRIC EMPTYING 7 0.0005
600 IRRITABLE BOWEL SYNDROME 11 0.0005
601 HAEMATEMESIS 13 0.0005
602 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0005
603 HYPERHIDROSIS 66 0.0005
604 VISUAL ACUITY REDUCED 17 0.0005
605 MALAISE 224 0.0005
606 GASTROINTESTINAL INFLAMMATION 4 0.0005
607 HEAD DISCOMFORT 9 0.0005
608 SWELLING FACE 33 0.0005
609 ATAXIA 6 0.0005
610 NEUROPATHY PERIPHERAL 48 0.0005
611 THIRST 9 0.0005
612 BLOOD PRESSURE ABNORMAL 10 0.0005
613 RASH 219 0.0005
614 MEMORY IMPAIRMENT 69 0.0005
615 UPPER LIMB FRACTURE 10 0.0005
616 SCIATICA 8 0.0005
617 NEPHROLITHIASIS 23 0.0005
618 CORONARY ARTERY DISEASE 15 0.0005
619 OSTEOARTHRITIS 21 0.0005
620 RASH MACULO-PAPULAR 11 0.0005
621 PAIN IN JAW 14 0.0005
622 ALOPECIA 97 0.0005
623 FEEDING DISORDER 10 0.0005
624 TOOTH ABSCESS 5 0.0005
625 HALLUCINATION 37 0.0005
626 BLINDNESS 20 0.0005
627 EAR DISCOMFORT 5 0.0005
628 HYPERAESTHESIA 4 0.0005
629 HYPERTENSION 103 0.0005
630 BALANCE DISORDER 42 0.0005
631 INJECTION SITE HAEMATOMA 7 0.0005
632 DRY MOUTH 39 0.0005
633 TINNITUS 22 0.0005
634 LIMB INJURY 13 0.0005
635 TRANSFUSION 5 0.0005
636 PERICARDITIS 8 0.0005
637 PRODUCT DOSE OMISSION 31 0.0005
638 CARDIOVASCULAR DISORDER 12 0.0005
639 PULMONARY MASS 7 0.0005
640 INSOMNIA 125 0.0005
641 THROAT IRRITATION 21 0.0005
642 PRURITUS 178 0.0005
643 LACTIC ACIDOSIS 15 0.0005
644 PRODUCT PRESCRIBING ERROR 11 0.0005
645 EYE PAIN 26 0.0005
646 PRODUCT PRESCRIBING ISSUE 10 0.0005
647 LOCALISED INFECTION 11 0.0005
648 DISORIENTATION 18 0.0005
649 PRODUCT COMMUNICATION ISSUE 4 0.0005
650 HYPERTENSIVE CRISIS 5 0.0004
651 SPINAL FRACTURE 9 0.0004
652 GLOSSODYNIA 10 0.0004
653 INTESTINAL PERFORATION 5 0.0004
654 CYANOSIS 7 0.0004
655 SINUS CONGESTION 6 0.0004
656 PRODUCT TASTE ABNORMAL 6 0.0004
657 NASAL CONGESTION 26 0.0004
658 OPTIC NEURITIS 4 0.0004
659 IMPAIRED DRIVING ABILITY 5 0.0004
660 URINARY INCONTINENCE 13 0.0004
661 METABOLIC ACIDOSIS 14 0.0004
662 PROSTATIC SPECIFIC ANTIGEN INCREASED 6 0.0004
663 DRUG INTOLERANCE 42 0.0004
664 SEPSIS 48 0.0004
665 LACRIMATION INCREASED 13 0.0004
666 APHONIA 6 0.0004
667 CARPAL TUNNEL SYNDROME 6 0.0004
668 APPENDICITIS 4 0.0004
669 BONE PAIN 25 0.0004
670 SKIN EXFOLIATION 36 0.0004
671 CONSTIPATION 93 0.0004
672 FEELING HOT 26 0.0004
673 BLOOD IRON DECREASED 5 0.0004
674 HYPOAESTHESIA 63 0.0004
675 PAIN IN EXTREMITY 124 0.0004
676 BACK PAIN 97 0.0004
677 WRIST FRACTURE 5 0.0004
678 FACE OEDEMA 7 0.0004
679 HERNIA 8 0.0004
680 ERYTHEMA 85 0.0004
681 PRODUCT DISPENSING ERROR 9 0.0004
682 ADVERSE EVENT 38 0.0004
683 HYPOGLYCAEMIA 20 0.0004
684 NECK PAIN 23 0.0004
685 DRUG DOSE OMISSION 68 0.0004
686 APATHY 6 0.0004
687 CHOKING 8 0.0004
688 NO THERAPEUTIC RESPONSE 5 0.0004
689 COELIAC DISEASE 4 0.0004
690 HEPATOMEGALY 4 0.0004
691 KNEE OPERATION 4 0.0004
692 SMALL INTESTINAL OBSTRUCTION 5 0.0004
693 HOSPICE CARE 4 0.0004
694 NIGHTMARE 14 0.0004
695 SINUS DISORDER 8 0.0004
696 PHARYNGITIS 5 0.0004
697 BLADDER DISORDER 4 0.0004
698 CONFUSIONAL STATE 65 0.0004
699 HEPATIC FUNCTION ABNORMAL 15 0.0004
700 HAIR COLOUR CHANGES 5 0.0004
701 SECRETION DISCHARGE 5 0.0004
702 BRAIN INJURY 4 0.0004
703 VOMITING 186 0.0004
704 ABDOMINAL PAIN LOWER 10 0.0004
705 TASTE DISORDER 8 0.0004
706 WOUND 11 0.0004
707 GALLBLADDER DISORDER 7 0.0004
708 SINUSITIS 40 0.0004
709 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 79 0.0004
710 ERECTILE DYSFUNCTION 10 0.0004
711 PRODUCT DOSE OMISSION IN ERROR 11 0.0004
712 TOOTH LOSS 8 0.0004
713 HEADACHE 241 0.0004
714 CHILLS 45 0.0004
715 RHABDOMYOLYSIS 16 0.0004
716 ACCIDENTAL OVERDOSE 14 0.0004
717 ARTHRALGIA 159 0.0004
718 SPEECH DISORDER 20 0.0004
719 ORAL CANDIDIASIS 5 0.0004
720 IMMUNE SYSTEM DISORDER 5 0.0004
721 HALLUCINATION, VISUAL 8 0.0004
722 FULL BLOOD COUNT ABNORMAL 4 0.0004
723 RESPIRATORY TRACT CONGESTION 6 0.0004
724 HOSPITALISATION 58 0.0004
725 VERTIGO 23 0.0004
726 ADVERSE REACTION 5 0.0004
727 CELLULITIS 19 0.0004
728 EYE SWELLING 14 0.0004
729 EATING DISORDER 8 0.0004
730 BREAST PAIN 4 0.0004
731 ASTHMA 42 0.0004
732 SKIN CANCER 8 0.0004
733 NEURALGIA 9 0.0004
734 GASTRIC ULCER 7 0.0004
735 PROTEINURIA 7 0.0004
736 INCORRECT DOSE ADMINISTERED 84 0.0004
737 TACHYPNOEA 5 0.0004
738 SEPTIC SHOCK 16 0.0004
739 MYOCARDIAL INFARCTION 64 0.0004
740 PULMONARY THROMBOSIS 4 0.0004
741 CHOLELITHIASIS 12 0.0004
742 INTENTIONAL PRODUCT MISUSE 32 0.0004
743 LUNG NEOPLASM MALIGNANT 15 0.0004
744 POST PROCEDURAL COMPLICATION 7 0.0004
745 LOWER LIMB FRACTURE 7 0.0004
746 DYSGEUSIA 27 0.0004
747 PARAESTHESIA 57 0.0004
748 MOBILITY DECREASED 26 0.0004
749 DENTAL CARIES 4 0.0004
750 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
751 NERVE INJURY 4 0.0004
752 DEPRESSED MOOD 19 0.0004
753 HOT FLUSH 27 0.0004
754 SKIN FISSURES 7 0.0004
755 SOMNOLENCE 72 0.0004
756 MALNUTRITION 4 0.0004
757 RASH PAPULAR 8 0.0004
758 KIDNEY INFECTION 7 0.0004
759 THERAPEUTIC RESPONSE UNEXPECTED 16 0.0004
760 PLATELET COUNT DECREASED 38 0.0004
761 OROPHARYNGEAL PAIN 33 0.0004
762 MYOCARDIAL ISCHAEMIA 4 0.0004
763 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25 0.0004
764 MUSCULOSKELETAL DISCOMFORT 6 0.0003
765 NASOPHARYNGITIS 64 0.0003
766 PRODUCT PHYSICAL ISSUE 7 0.0003
767 MYELODYSPLASTIC SYNDROME 5 0.0003
768 ANOSMIA 5 0.0003
769 MADAROSIS 4 0.0003
770 ANXIETY 98 0.0003
771 MUCOSAL INFLAMMATION 9 0.0003
772 GASTROENTERITIS 5 0.0003
773 ANGIOEDEMA 15 0.0003
774 DRUG ERUPTION 6 0.0003
775 BLISTER 19 0.0003
776 AMNESIA 22 0.0003
777 RENAL INJURY 10 0.0003
778 COLON CANCER 5 0.0003
779 ACCIDENT 4 0.0003
780 VIRAL INFECTION 11 0.0003
781 STOMATITIS 20 0.0003
782 HYPERSENSITIVITY 61 0.0003
783 RETCHING 7 0.0003
784 PYREXIA 113 0.0003
785 HIP ARTHROPLASTY 5 0.0003
786 ECZEMA 17 0.0003
787 EMOTIONAL DISORDER 10 0.0003
788 CONJUNCTIVITIS 6 0.0003
789 CYST 4 0.0003
790 DELUSION 5 0.0003
791 BASAL CELL CARCINOMA 5 0.0003
792 MUSCLE ATROPHY 4 0.0003
793 INTRAOCULAR PRESSURE INCREASED 4 0.0003
794 HYPOPHAGIA 8 0.0003
795 SNEEZING 7 0.0003
796 URTICARIA 52 0.0003
797 NIGHT SWEATS 10 0.0003
798 MUSCLE TIGHTNESS 5 0.0003
799 EAR PAIN 6 0.0003
800 DIPLOPIA 8 0.0003
801 MEDICATION ERROR 17 0.0003
802 INCORRECT PRODUCT STORAGE 4 0.0003
803 EYE DISORDER 10 0.0003
804 DISABILITY 6 0.0003
805 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
806 C-REACTIVE PROTEIN INCREASED 11 0.0003
807 PRODUCT QUALITY ISSUE 41 0.0003
808 PRESCRIBED UNDERDOSE 6 0.0003
809 VAGINAL HAEMORRHAGE 13 0.0003
810 JOINT RANGE OF MOTION DECREASED 4 0.0003
811 QUALITY OF LIFE DECREASED 4 0.0003
812 APHASIA 9 0.0003
813 PALLOR 8 0.0003
814 BLOOD GLUCOSE DECREASED 14 0.0003
815 MENTAL IMPAIRMENT 7 0.0003
816 CEREBRAL INFARCTION 7 0.0003
817 DERMATITIS 6 0.0003
818 EOSINOPHILIA 5 0.0003
819 FLUSHING 29 0.0003
820 BLOOD TEST ABNORMAL 4 0.0003
821 INJURY 20 0.0003
822 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
823 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
824 DRY EYE 14 0.0003
825 BRONCHOSPASM 4 0.0003
826 PARALYSIS 4 0.0003
827 HERPES ZOSTER 16 0.0003
828 PAIN 171 0.0003
829 IMPAIRED QUALITY OF LIFE 4 0.0003
830 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
831 INFECTION 40 0.0003
832 MENTAL DISORDER 12 0.0003
833 PANIC ATTACK 10 0.0003
834 OCULAR HYPERAEMIA 13 0.0003
835 ILLNESS 28 0.0003
836 STEVENS-JOHNSON SYNDROME 6 0.0003
837 THROMBOCYTOPENIA 30 0.0003
838 PANCREATITIS ACUTE 6 0.0003
839 JOINT STIFFNESS 7 0.0003
840 DRY SKIN 35 0.0003
841 INCREASED APPETITE 5 0.0003
842 TOXICITY TO VARIOUS AGENTS 44 0.0003
843 DRUG PRESCRIBING ERROR 5 0.0003
844 LEUKOPENIA 13 0.0003
845 GLAUCOMA 5 0.0003
846 THROAT TIGHTNESS 7 0.0003
847 FEMUR FRACTURE 8 0.0003
848 BLOOD CHOLESTEROL INCREASED 12 0.0003
849 COVID-19 45 0.0003
850 PLASMA CELL MYELOMA 10 0.0003
851 DRUG INEFFECTIVE 337 0.0003
852 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
853 PNEUMOTHORAX 4 0.0003
854 DIABETES MELLITUS 19 0.0002
855 THROMBOSIS 20 0.0002
856 PRODUCT ADMINISTRATION ERROR 5 0.0002
857 PRODUCT USE ISSUE 46 0.0002
858 ENCEPHALOPATHY 6 0.0002
859 HYPERSOMNIA 7 0.0002
860 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 44 0.0002
861 STAPHYLOCOCCAL INFECTION 8 0.0002
862 DRUG EFFECT DECREASED 13 0.0002
863 EXPIRED PRODUCT ADMINISTERED 8 0.0002
864 LIP SWELLING 8 0.0002
865 NEOPLASM MALIGNANT 16 0.0002
866 GAIT INABILITY 8 0.0002
867 INTENTIONAL DRUG MISUSE 5 0.0002
868 CARDIO-RESPIRATORY ARREST 10 0.0002
869 ROAD TRAFFIC ACCIDENT 10 0.0002
870 SURGERY 14 0.0002
871 EYE PRURITUS 8 0.0002
872 DEPRESSION 54 0.0002
873 CANDIDA INFECTION 4 0.0002
874 ARTHROPATHY 13 0.0002
875 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
876 INFLUENZA 26 0.0002
877 UNRESPONSIVE TO STIMULI 6 0.0002
878 DEATH 200 0.0002
879 SKIN ULCER 6 0.0002
880 DEEP VEIN THROMBOSIS 15 0.0002
881 METASTASES TO LIVER 4 0.0002
882 CONVULSION 13 0.0002
883 FEAR 6 0.0002
884 GASTROENTERITIS VIRAL 4 0.0002
885 OSTEOMYELITIS 4 0.0002
886 SKIN LESION 6 0.0002
887 RESPIRATORY ARREST 6 0.0002
888 SHOCK 5 0.0002
889 PROCEDURAL PAIN 6 0.0002
890 THERAPY CESSATION 11 0.0002
891 INFLAMMATION 11 0.0002
892 INTESTINAL OBSTRUCTION 8 0.0002
893 FRACTURE 4 0.0002
894 MUSCULOSKELETAL DISORDER 4 0.0002
895 COMA 10 0.0002
896 INFLUENZA LIKE ILLNESS 17 0.0002
897 FIBROMYALGIA 5 0.0002
898 AGITATION 15 0.0002
899 PRODUCT DOSE OMISSION ISSUE 60 0.0002
900 LABORATORY TEST ABNORMAL 6 0.0002
901 OESOPHAGEAL CARCINOMA 6 0.0002
902 PULMONARY EMBOLISM 19 0.0002
903 BLOOD GLUCOSE INCREASED 37 0.0002
904 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
905 OSTEOPOROSIS 8 0.0002
906 PRODUCT USE IN UNAPPROVED INDICATION 48 0.0002
907 DRUG EFFECT INCOMPLETE 7 0.0002
908 CRYING 7 0.0002
909 NERVOUS SYSTEM DISORDER 6 0.0002
910 EYE IRRITATION 11 0.0002
911 EAR INFECTION 5 0.0002
912 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
913 BLADDER CANCER 11 0.0002
914 DISTURBANCE IN ATTENTION 10 0.0002
915 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
916 IMPAIRED HEALING 6 0.0002
917 INTENTIONAL PRODUCT USE ISSUE 16 0.0002
918 MUSCULOSKELETAL STIFFNESS 16 0.0002
919 ILL-DEFINED DISORDER 11 0.0002
920 ORAL PAIN 4 0.0002
921 DISEASE PROGRESSION 21 0.0002
922 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
923 ABNORMAL BEHAVIOUR 7 0.0002
924 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
925 PRODUCT AVAILABILITY ISSUE 4 0.0002
926 INTENTIONAL DOSE OMISSION 5 0.0002
927 INJECTION SITE HAEMORRHAGE 14 0.0002
928 SUICIDAL IDEATION 16 0.0002
929 DYSKINESIA 7 0.0002
930 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
931 LYMPHADENOPATHY 6 0.0002
932 DISEASE RECURRENCE 8 0.0002
933 SKIN BURNING SENSATION 12 0.0002
934 TREATMENT NONCOMPLIANCE 9 0.0002
935 PANCYTOPENIA 9 0.0002
936 PSORIASIS 21 0.0002
937 PNEUMONIA ASPIRATION 4 0.0002
938 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
939 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
940 COLITIS ULCERATIVE 7 0.0002
941 DEVICE MALFUNCTION 11 0.0002
942 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
943 MOVEMENT DISORDER 5 0.0002
944 EXPOSURE VIA SKIN CONTACT 4 0.0002
945 SKIN IRRITATION 7 0.0002
946 ANGER 5 0.0001
947 PSORIATIC ARTHROPATHY 6 0.0001
948 MOOD ALTERED 4 0.0001
949 MIGRAINE 14 0.0001
950 ADVERSE DRUG REACTION 13 0.0001
951 DELIRIUM 5 0.0001
952 DEVICE LEAKAGE 6 0.0001
953 NEEDLE ISSUE 4 0.0001
954 DEVICE ISSUE 12 0.0001
955 THERAPY NON-RESPONDER 6 0.0001
956 IRRITABILITY 8 0.0001
957 INJECTION SITE RASH 4 0.0001
958 PROSTATE CANCER 10 0.0001
959 PRODUCT SUBSTITUTION ISSUE 7 0.0001
960 TREATMENT FAILURE 10 0.0001
961 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
962 INJECTION SITE PAIN 36 0.0001
963 OVERDOSE 24 0.0001
964 NO ADVERSE EVENT 20 0.0001
965 HYPERGLYCAEMIA 4 0.0001
966 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
967 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
968 FEBRILE NEUTROPENIA 7 0.0001
969 COLITIS 4 0.0001
970 PRODUCT STORAGE ERROR 9 0.0001
971 INJECTION SITE BRUISING 8 0.0001
972 DEVICE BREAKAGE 4 0.0001
973 THERAPY INTERRUPTED 7 0.0001
974 RHEUMATOID ARTHRITIS 11 0.0001
975 INFUSION RELATED REACTION 6 0.0001
976 INJECTION SITE REACTION 6 0.0001
977 SEIZURE 10 0.0001
978 COGNITIVE DISORDER 4 0.0001
979 NEUTROPENIA 11 0.0001
980 ACNE 6 0.0001
981 INJECTION SITE SWELLING 6 0.0001
982 BREAST CANCER 7 0.0001
983 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
984 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
985 ANAPHYLACTIC REACTION 4 0.0001
986 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
987 INJECTION SITE PRURITUS 4 0.0001
988 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
989 INJECTION SITE ERYTHEMA 7 0.0001
990 DRUG DOSE OMISSION BY DEVICE 4 0.0001
991 DRUG DEPENDENCE 4 0.0000